# COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA

> **NCT03649061** · PHASE4 · COMPLETED · sponsor: **P. Verschueren** · enrollment: 276 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Etanercept 50 MG/ML
- **DRUG:** Leflunomide 10 milligram (MG)

## Key facts

- **NCT ID:** NCT03649061
- **Lead sponsor:** P. Verschueren
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-08
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2025-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03649061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03649061, "COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03649061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*